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Abstract: In human addicts, drug relapse and craving are often provoked by
stress. Since 1995, this clinical scenario has been studied using a rat model of
stress-induced reinstatement of drug seeking. Here, we first discuss the
generality of stress-induced reinstatement to different drugs of abuse,
different stressors, and different behavioral procedures. We also discuss
neuropharmacological mechanisms, and brain areas and circuits controlling
stress-induced reinstatement of drug seeking. We conclude by discussing
results from translational human laboratory studies and clinical trials that
were inspired by results from rat studies on stress-induced reinstatement.
Our main conclusions are (1) The phenomenon of stress-induced
reinstatement, first shown with an intermittent footshock stressor in rats
trained to self-administer heroin, generalizes to other abused drugs, including
cocaine, methamphetamine, nicotine, and alcohol, and is also observed in the
conditioned place preference model in rats and mice. This phenomenon,
however, is stressor specific and not all stressors induce reinstatement of
drug seeking. (2) Neuropharmacological studies indicate the involvement of
corticotropin-releasing factor (CRF), noradrenaline, dopamine, glutamate,
kappa/dynorphin, and several other peptide and neurotransmitter systems in
stress-induced reinstatement. Neuropharmacology and circuitry studies
indicate the involvement of CRF and noradrenaline transmission in bed
nucleus of stria terminalis and central amygdala, and dopamine, CRF,
kappa/dynorphin, and glutamate transmission in other components of the
mesocorticolimbic dopamine system (ventral tegmental area, medial
prefrontal cortex, orbitofrontal cortex, and nucleus accumbens). (3)
Translational human laboratory studies and a recent clinical trial study show
the efficacy of alpha-2 adrenoceptor agonists in decreasing stress-induced
drug craving and stress-induced initial heroin lapse.

Introduction
A central feature of drug addiction is the high rate of relapse
during abstinence (Hunt et al, 1971; O'Brien, 2005). Over the years,
results from many correlational human studies have suggested that
this relapse is often provoked by stress (Box 1) (Khantzian, 1985;
Shiffman and Wills, 1985; Kosten et al, 1986). These clinical studies
have led to the development of a rat model, which is based on the
operant conditioning reinstatement model (Stewart and de Wit, 1987),
to study mechanisms of stress-induced relapse to drug seeking
(Shaham et al, 2000a). In the reinstatement model, laboratory
animals are tested for reinstatement of drug seeking induced by drug
priming, discrete cues, discriminative cues, contextual cues, or
stressors, following drug self-administration training (typically lever
pressing or nose poking for drug infusions) and subsequent extinction
of the drug-reinforced responding (Shaham et al, 2003; Stewart and
de Wit, 1987). The first study using the reinstatement model was
Neuropsychopharmacology, Vol 41, No. 1 (January 2016): pg. 335-356. DOI. This article is © © 2016 American College of
Neuropsychopharmacology and permission has been granted for this version to appear in e-Publications@Marquette.
American College of Neuropsychopharmacology does not grant permission for this article to be further
copied/distributed or hosted elsewhere without the express permission from American College of
Neuropsychopharmacology.

2

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

published in 1995 using male and female rats that were trained to selfadminister heroin for 12 days for 12 h/day. In this study, acute
exposure to 10 min of intermittent footshock stress immediately before
the test sessions reinstated heroin seeking after 1–2 weeks of
extinction training and after an additional 4- to 6-week drug-free
period (Shaham and Stewart, 1995) (Figure 1).

Figure 1. Effect of intermittent footshock stress on reinstatement across drug classes.
Data are mean±SEM non-reinforced active lever presses after exposure to intermittent
footshock or no shock immediately before the reinstatement tests in rats with a
history of heroin, cocaine, alcohol, nicotine, or methamphetamine self-administration.
The session duration was 3 h for heroin and cocaine, 1 h for alcohol and nicotine, and
2 h for methamphetamine. The intermittent footshock (0.5 s ON; mean inter-shockinterval 40 s) duration was 10 min for heroin and cocaine, 5 min for alcohol and
methamphetamine, and 15 min for nicotine. Data were redrawn from Buczek et al
(1999), Erb et al (1996), Le et al (1998), Shaham and Stewart (1995), and Shepard
et al (2004). *Different from the no stress condition, p<0.05.

Box 1. The Stress Concept
Stress is a complex psychological construct that despite many
decades of research (Cannon, 1935; Selye, 1936) lacks a singular
operational definition (Chrousos and Gold, 1992; Cohen et al, 1982).
In animal models of psychiatric disorders, stress can be broadly
defined as forced exposure to events or conditions that are normally
avoided (Piazza and Le Moal, 1998). In humans, the stress definition is
often extended to incorporate cognitive and emotional responses as
suggested by Cohen et al (1986): ‘stress is a condition in which the
environmental demands exceed the coping abilities of the individual.'
In laboratory animals, the precipitating events or conditions can be
divided into two main categories (Lu et al, 2003). The first includes
aversive conditions like restraint, footshock, tail pinch, social defeat, or
pharmacological stressors like exogenous CRF that the rat would avoid
if given the opportunity. The second includes conditions like food
deprivation, social isolation, or maternal deprivation; each consists of
the removal of an environmental condition that is important for
maintaining the animal's normal steady-state conditions, a state that
the subject will attempt to ameliorate by seeking food, conspecific
partners, or the dam.
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In this review, we summarize results from studies published
during the last 20 years in which investigators have used different
variations of the stress-induced reinstatement model to study
behavioral, neuropharmacological, and neuroanatomical mechanisms
of stress-induced reinstatement of drug seeking. We also summarize
results from human studies that have determined the degree to which
the results from the preclinical studies ‘translate' to the human
condition. The material in our review overlaps to some degree with
previous reviews (Bossert et al, 2005, 2013; Lu et al, 2003; Mantsch
et al, 2014; Shaham et al, 2003; Shalev et al, 2010, 2002; Sinha et
al, 2011b), but provides the only comprehensive review uniquely
dedicated to the phenomenon of stress-induced reinstatement across
drug classes since an early review in 2000 (Shaham et al, 2000a).
Since 1995, over 200 papers have been published on this phenomenon
(PubMed, Figure 2). Due to space limitations, we do not cover all
published papers on this topic in our review.

Figure 2. Publications on stress-induced reinstatement. Number of preclinical
publications per 5-year period on stress-induced reinstatement of drug selfadministration and CPP since 1995.
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Generality of Stress-Induced Reinstatement
Generality to Other Drug and Non-Drug Rewards
Early studies showed that the effect of intermittent footshock on
reinstatement of heroin seeking generalized to male rats with a history
of cocaine (Erb et al, 1996), alcohol (Le et al, 1998), nicotine (Buczek
et al, 1999), and methamphetamine (Shepard et al, 2004) selfadministration (Figure 1). In contrast, several early studies showed
that exposure to an intermittent footshock stressor that reinstates
drug seeking (Shaham et al, 2000a) does not reinstate food reward
seeking in male rats trained to self-administer food pellets (Ahmed and
Koob, 1997), sucrose pellets (Le et al, 1998; Mantsch and Goeders,
1999), or sucrose solution (Buczek et al, 1999). However, more
recently, Chen et al (2014b) showed that intermittent footshock
modestly reinstates palatable food (high carbohydrate pellets) seeking
in female rats with a history of ‘cafeteria diet' consumption during
adolescence. There is also evidence that intermittent footshock stress
reinstates operant responding previously reinforced by brain
stimulation reward (Shalev et al, 2000); this finding is in agreement
with results from an early study (Deutch and Howarth, 1962). In the
studies described above, and in others reviewed below, the
intermittent footshock stressor and other stressors (with the exception
of 1 day food deprivation) were administered acutely just before the
reinstatement test sessions.
The reasons for the ‘selective' effect of intermittent footshock
stress on reinstatement of drug vs food reward are unknown. As
previously discussed, one possibility is that while certain physiological
effects of intermittent footshock promote reward seeking, other effects
of footshock induce physiological states that inhibit food intake and
seeking (Shaham et al, 2000a). In this regard, one potential
mechanism is hypothalamic corticotropin releasing factor (CRF), which
is released after exposure to footshock and other stressors (Bale and
Vale, 2004; Sawchenko et al, 2000), and causes inhibition of food
intake (Glowa et al, 1992; Morley and Levine, 1982; Sekino et al,
2004). As discussed below (section ‘Brain areas and circuits of stressinduced reinstatement'), this classical effect of CRF on the
hypothalamic-pituitary adrenal (HPA) axis (Dallman et al, 1995)
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contrasts with CRF actions on extrahypothalamic systems, which
promote stress-induced reinstatement of drug seeking (Erb et al,
2001b). It is also possible that the ‘putative' selective effect of
intermittent footshock on reinstatement of drug vs food seeking is due
to the fact that the above negative studies with food were performed
under experimental conditions in which footshock stress-induced
reinstatement is often not observed with drugs like cocaine (eg,
limited access daily sessions) (see section ‘Methodological
considerations').

Generality to Other Behavioral Procedures
In the studies described in section ‘Generality to other drug and
non-drug rewards', footshock stress-induced reinstatement was
determined using the operant version of the extinction-reinstatement
model (Shaham et al, 2003). The effect of this stressor was also
demonstrated in the conditioned place preference (CPP) variation of
the model using cocaine (Wang et al, 2000). In the CPP reinstatement
model, laboratory animals are trained to associate a distinct
environment with drug injections, undergo extinction training during
which they are exposed to the drug environment in the absence of
drug, and then tested for reinstatement of drug CPP after stress
exposure (Sanchez and Sorg, 2001; Wang et al, 2000). There is also
evidence that intermittent footshock can re-establish morphine or
cocaine CPP under experimental conditions in which the drug CPP is no
longer observed after the passage of time without extinction training
(Lu et al, 2000, 2001). Reinstatement of drug seeking after extinction
has also been assessed in the runway operant model (Ettenberg,
2009; Ettenberg et al, 1996). To date, however, we are not aware of
published studies on the effect of intermittent footshock or other
stressors on reinstatement of drug seeking in this model.

Generality to Other Stressors
Over the years, investigators have determined whether
stressors other than intermittent footshock reinstate operant drug
seeking or drug CPP. We discuss these results separately for the selfadministration and CPP variations of the reinstatement model. Table 1
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provides a summary of the text in section ‘Generality to other
stressors'.
Table 1. Effects of Different Stressors on Reinstatement of Operant
Drug Seeking and Conditioned Place Preference (CPP)
Self-administration

CPP

Heroin Cocaine METH Nicotine Alcohol Morphine Cocaine
Environmental stressors
Intermittent Footshock

Yes

Yes

Food deprivation

Yes

Yes

Swim stress
Cue paired with shock

Yes

Yes

Yes
No

Yes

Yes

No
Yes

No

Yes

Social defeat

No

Cue paired with social
defeat
Restraint

Yes

Yes
Yes

Yes

Yes

Yes

Yes

Yes
No

Tail pinch

Yes

Quinine solution

Yes

Pharmacological and neuropharmacological stressors
CRF

Yes

Yes

Yohimbine

Yes

Yes

Kappa agonists

Yes

Yes

Yes

Yes

GABAA antagonists

No

Metyrapone

Yes

Medial septum inactivation

Yes

No

Yes
Yes

No

Abbreviations: CRF, corticotropin-releasing factor; METH, methamphetamine.

Stress-induced reinstatement of drug self-administration. Acute
1-day food deprivation reinstates heroin and cocaine seeking (Shalev
et al, 2000, 2003); these results are in agreement with an earlier
finding that food restriction (about 30–40% of daily food ration)
reinstates cocaine seeking in rats with a history of exposure to this
stressor during the training phase (Carroll, 1985). Acute 1-day food
deprivation also reliably reinstates cocaine seeking in mice (Highfield
et al, 2002). Exposure to cues previously paired with social defeat
stress, but not acute exposure to social defeat, modestly reinstates
alcohol seeking (Funk et al, 2005). Conrad et al (2010) showed that
acute exposure (4–5 min) to cold swim stress 24 h before the
reinstatement tests reinstates cocaine seeking. Most recently, Twining
et al (2015) showed that acute intraoral delivery of an aversive bitter
quinine solution reinstates cocaine seeking.
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Pharmacological induction of a stress-like state by ventricular
CRF injections reinstates heroin (Shaham et al, 1997), alcohol (Le et
al, 2002), and cocaine (Erb et al, 2006) seeking. Similarly, systemic
injections of the alpha-2 adrenoceptor antagonist yohimbine, which
induces stress- and anxiety-like responses in humans and laboratory
animals (Bremner et al, 1996a and b), reinstate methamphetamine
(Shepard et al, 2004), alcohol (Le et al, 2005), cocaine (Feltenstein
and See, 2006), and nicotine (Feltenstein et al, 2012) seeking in rats,
and cocaine seeking in monkeys (Lee et al, 2004). However, the
relevance of the potent effect of yohimbine on reinstatement of drug
seeking to the general phenomenon of stress-induced reinstatement
has been questioned in a recent study (Chen et al, 2014c) (see Box 2).
Box 2. Yohimbine-Induced Reinstatement: does it Reflect
Stress-Induced Reinstatement?
Yohimbine is an alpha-2 adrenoceptor antagonist that has been
used in numerous psychiatry-related studies as a pharmacological
stressor in rodents, monkeys, and humans (Bremner et al, 1996a and
b; Redmond and Huang, 1979). Over the last decade, yohimbine has
become the most common stress manipulation in studies on
reinstatement of drug and food seeking (Bossert et al, 2013; Calu et
al, 2014; Nair et al, 2009) for three main reasons. The first is that the
effect of yohimbine on reinstatement is less variable and more robust
than the effect of intermittent footshock (Le et al, 2005; Shepard et al,
2004). The second is that early studies showed that like intermittent
footshock the effect of yohimbine on reinstatement of food and alcohol
is blocked by CRF1 receptor antagonists, which likely act at
extrahypothalamic brain areas (Ghitza et al, 2006; Marinelli et al,
2007). The third reason was the intuitive appeal of using the same
stressor in the animal model and in humans (Greenwald et al, 2013;
See and Waters, 2010).
However, with the increasing use of yohimbine in reinstatement
studies, evidence emerges for behavioral and pharmacological
differences between the effects of intermittent footshock and
yohimbine on reward seeking. Unlike footshock, yohimbine reinstates
food seeking and also increases alcohol and food self-administration
(Cifani et al, 2012; Le et al, 2005). Unlike intermittent footshock,
yohimbine does not induce stress-related 22 kHz ultrasonic distress
vocalizations (Mahler et al, 2013). Unlike intermittent footshock, the
effect of yohimbine on reinstatement of cocaine seeking or cocaine CPP
is not blocked by the alpha-2 adrenoceptor agonist clonidine (Brown et
al, 2009; Mantsch et al, 2010). These differences between yohimbine
and intermittent footshock raise the possibility that the effect of
yohimbine on reinstatement of reward seeking might not be due to its
ability to induce a stress-like state that motivates drug or food
seeking.
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This issue was addressed in a recent study by Chen et al
(2014c) in which they determined whether yohimbine's effect on
operant responding is dependent on previous reward history or cue
contingency, and whether yohimbine (at a dose used in reinstatement
studies) induces an aversive stress-like state, as assessed by the
CPP/CPA (conditioned place aversion) method. Chen et al reported that
the magnitude of yohimbine-induced operant responding during the
reinstatement tests was critically dependent on the contingency
between lever pressing and discrete tone-light cue delivery, but not
the previous history with food reward during training. Specifically,
yohimbine potently and dose-dependently increased operant leverpressing that was not previously reinforced with either food or drug.
They also showed that repeated pairing of yohimbine (2 mg/kg) with a
distinct context causes modest CPP to this context. The highly
unexpected conclusion from this study was that yohimbine's effects on
operant responding in reinstatement studies are likely independent of
the history of contingent self-administration of food or drug rewards
and may not be related to the commonly assumed stress-like effects of
yohimbine. Chen et al (2014c) proposed that the primary action of
yohimbine in reinstatement studies is to invigorate responding for
cues, which before pairing with drug or non-drug rewards or after
extinction, have weak motivational effects in rodents.

Another class of putative pharmacological stressors is kappa
opioid receptor (KOR) agonists, which induce stress-like states in
humans and laboratory animals (Bruchas et al, 2010; Van't Veer and
Carlezon, 2013). In rats, systemic injections of the KOR agonist
U50,488 reinstate nicotine and alcohol seeking (Funk et al, 2014;
Grella et al, 2014). In monkeys, systemic injections of KOR agonists
(spiradoline and enadoline) reinstate cocaine seeking (Valdez et al,
2007). Another potential demonstration of the effect of
pharmacological stressors on reinstatement is the finding that
metyrapone potently reinstates heroin seeking (Shaham et al, 1997).
Metyrapone is a corticosterone synthesis inhibitor (Jenkins et al, 1958)
that has been used in numerous endocrinology studies (Haynes,
1990). However, the drug also activates extrahypothalamic brain
areas, including the central amygdala (CeA) nucleus (Rotllant et al,
2002), which has an important role in stress-induced reinstatement
(section ‘Brain areas and circuits of stress-induced reinstatement').
Finally, another class of pharmacological stressors, GABAa antagonists
or inverse receptor agonists like pentylenetetrazole or FG7142, had no
effect on reinstatement of cocaine (Waters and See, 2011), heroin, or
alcohol (Y Shaham, AD Le, unpublished observations) seeking.
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One study showed that a cue previously paired with footshock
(a conditioned fear manipulation) reinstates alcohol seeking (Liu and
Weiss, 2003). However, earlier studies reported that conditioned fear
exposure has no effect on reinstatement of heroin or cocaine seeking
(Shaham et al, 2000a). A possible reason for the negative results is
that the predominant effect of cues paired with shock is freezing
(LeDoux, 2000), a behavior that is incompatible with lever-pressing
behavior. Exposure to restraint stress in a novel context had no effect
on reinstatement of heroin seeking (Shalev et al, 2000). As
intermittent footshock stress is effective when given in the drug selfadministration context, but has no effect on reinstatement of heroin
seeking when given in a novel context, a potential account for the
negative results with restraint stress is that the phenomenon of stressinduced reinstatement is context-specific (Shalev et al, 2000). Finally,
the effect of footshock on reinstatement of heroin seeking is mimicked
by reversible inactivation of the medial septum (Highfield et al, 2000).
Previous studies have shown that septal lesions cause stress-like
physiological and psychological responses (Gray, 1987; Holdstock,
1967).

Stress-induced reinstatement of CPP. Exposure to several stressors
induces reinstatement of drug CPP after extinction in rats and mice.
Swim stress reinstates cocaine CPP in mice (Carey et al, 2007;
Kreibich and Blendy, 2004; Redila and Chavkin, 2008) and morphine
CPP in rats (Li et al, 2013; Ma et al, 2007). Restraint stress reinstates
cocaine CPP in rats (Sanchez et al, 2003) and morphine CPP in mice
(Ribeiro Do Couto et al, 2006). Tail pinch and social defeat reinstate
morphine CPP in mice (Ribeiro Do Couto et al, 2006). A conditioned
fear manipulation reinstates cocaine CPP in rats (Sanchez and Sorg,
2001). Additionally, as in the operant reinstatement model, systemic
injections of the putative pharmacological stressors U50,488 (a KOR
agonist) (Redila and Chavkin, 2008) and yohimbine (Mantsch et al,
2010) reinstate cocaine CPP in mice. However, 1-day food deprivation,
which reinstates operant heroin seeking in rats (Shalev et al, 2000),
has no effect on reinstatement of morphine CPP (Ma et al, 2007).
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Methodological Considerations
In the sections above, we summarize results from studies in
which stressors reinstate drug seeking and CPP. However, particularly
in the case of the intermittent footshock stressor, whether or not the
stressor reinstates operant drug seeking is dependent on several
critical methodological factors. One factor is the context of footshock
exposure: under identical experimental conditions, intermittent
footshock reinstates heroin seeking when it is administered in the drug
self-administration context but not in a novel context (Shalev et al,
2000). These findings are in agreement with results from conditioned
fear studies where a footshock previously paired with a conditioned
stimulus (CS) reinstates the response to the CS after extinction only
when rats are exposed to the stressor in the training context, but not
in a novel context (Bouton and King, 1983; Bouton and
Swartzentruber, 1991).
A second factor is the duration of the withdrawal period. Shalev
et al (2001) used a variation of the reinstatement model in which
extinction of operant responding and subsequent footshock-induced
reinstatement is determined in the same daily session (Shalev et al,
2002) to demonstrate the time-dependent changes in this
reinstatement after withdrawal from heroin. The stressor reinstated
heroin seeking after 6, 12, 25, and 66 withdrawal days but not after 1
day. In this study, the magnitude of stress-induced reinstatement was
maximal after 6 or 12 days.
A third factor is the amount of drug intake during drug selfadministration training. For both heroin (Ahmed et al, 2000) and
cocaine (Mantsch et al, 2008), intermittent footshock-induced
reinstatement of drug seeking is higher in magnitude and more
robust/reliable in rats with a history of extended daily drug access (6–
11 h/day) than in rats with a history of limited daily drug access (1–
2 h/day).
A fourth factor is the availability of discrete infusion cues during
all phases of the experiment (training, extinction, and reinstatement).
Shelton and Beardsley (2005) showed that under identical
experimental conditions, intermittent footshock reinstates cocaine
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seeking in the presence but not in the absence of a discrete infusion
cue previously paired with cocaine infusions during training. This
finding is in agreement with the notion that a potential mechanism for
footshock-induced reinstatement is that the stressor reinstates the
incentive motivational effects of drug cues (Shaham and Stewart,
1995). Additional support for this notion is that intermittent footshock
potentiates cue-induced reinstatement of cocaine and alcohol seeking
(Buffalari and See, 2009; Liu and Weiss, 2002a). In the cue-induced
reinstatement procedure, an operant response reinforced by a discrete
drug cue is determined after drug self-administration training in the
presence of the cue and extinction training in its absence (Meil and
See, 1996).
A fifth factor is baseline stress levels before footshock exposure
during the reinstatement tests. In general, while this variable has not
been experimentally manipulated like the other factors described
above, anecdotal evidence suggests that footshock-induced
reinstatement is not readily observed when the baseline stress level is
high, because under these conditions the predominant effect of the
stressor during the reinstatement test is prolonged freezing. This idea
has led to the development of a modified stress-induced reinstatement
procedure in which rats are first given several days of extinction
training, and during the subsequent reinstatement test they are given
several hours of extinction training before footshock exposure (Erb et
al, 1996; Kupferschmidt et al, 2011). Presumably, intermittent
footshock reliably reinstates drug seeking in this procedure because
the rat's basal stress level is relatively low several hours after being
exposed to non-specific stressors (eg, handling and transferred from
the animal facility to the test chambers).

Summary
The phenomenon of intermittent footshock stress-induced
reinstatement of drug seeking, originally reported with heroin-trained
rats, generalizes to other drugs of abuse and is also observed in the
CPP variation of the reinstatement model. This phenomenon also
generalizes to certain environmental and pharmacological stressors
but not others. Additionally, it appears that the number of stressors
that are effective in the CPP variation of the reinstatement model is
Neuropsychopharmacology, Vol 41, No. 1 (January 2016): pg. 335-356. DOI. This article is © © 2016 American College of
Neuropsychopharmacology and permission has been granted for this version to appear in e-Publications@Marquette.
American College of Neuropsychopharmacology does not grant permission for this article to be further
copied/distributed or hosted elsewhere without the express permission from American College of
Neuropsychopharmacology.

12

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

more diverse than in the operant variation of the model (Table 1).
Furthermore, several methodological factors are critical for a reliable
effect of intermittent footshock stress on reinstatement of drug
seeking. These factors include the context of footshock exposure, high
drug intake during training, the withdrawal period duration, the
presence of the extinguished discrete drug cues during testing, and
basal (baseline) stress levels before footshock exposure in the
reinstatement tests.
Finally, in all the published studies on stress-induced
reinstatement, the reinstating stressors have been both uncontrollable
and unpredictable. Thus, a question for future research is whether
these features of stressors are critical for their effect on reinstatement
of drug seeking. Based on previous studies investigating the inhibitory
effect of both stress controllability and predictability on physiological
and psychological stress responses in laboratory animals (Maier, 1984;
Seligman and Maier, 1967) and humans (Cohen et al, 1986; Glass and
Singer, 1972), we predict that controllable or predictable stressors will
have a weak effect on reinstatement of drug seeking. Additionally, in
the studies reviewed above, the stressors were administered acutely
before the reinstatement test session. Thus, another question for
future research is whether prior exposure to stress, which often leads
to subsequent sensitization of stress responses (Antelman et al, 2000;
Kvetnansky et al, 2009) and cross sensitization of the behavioral and
neurochemical responses to drugs (Kalivas and Stewart, 1991), would
potentiate the stressors' effect on reinstatement of drug seeking.

Brain Areas and Circuits of Stress-Induced
Reinstatement
Since 1995 many studies have determined the effects of
systemic and intracranial injections of pharmacological agents
targeting different receptor classes on stress-induced reinstatement of
drug seeking or CPP. Due to space limitations, we summarize most of
the systemic pharmacology data in Tables 2 and and33 but do not
discuss them in detail in our review. The brain circuitry data that we
discuss below are primarily based on the use of intermittent footshock
in the self-administration- and CPP-based reinstatement models with
different drug classes in rats, and the use of swim stress in the CPPNeuropsychopharmacology, Vol 41, No. 1 (January 2016): pg. 335-356. DOI. This article is © © 2016 American College of
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based procedure with cocaine in mice. During the last several years,
many investigators have also determined the neuropharmacological
mechanisms underlying yohimbine-induced reinstatement of drug
seeking and CPP (Bossert et al, 2013; Mantsch et al, 2014; See and
Waters, 2010). However, as discussed in Box 2, yohimbine's effects on
operant responding during reinstatement testing are likely
independent of the history of contingent drug self-administration and
may not be related to the commonly assumed stress-like effects of
yohimbine. Therefore, we only mention results from yohimbine-related
studies when a given neuropharmacological manipulation affected both
intermittent footshock- and yohimbine-induced reinstatement.
Table 2. Effect of Systemic Injections of Different Pharmacological
Agents on Stress-Induced Reinstatement of Operant Drug and Food
Seeking
Neurotransmitter/hormonal
systems and drugs

Species Training Stressor Effect
history

References

CRF
Rat,
mouse

A, C, F,
H, N

FS, Y

↓

Gehlert et al (2007),
Ghitza et al (2006),
Hansson et al (2006), Le
et al (2000), Marinelli et
al (2007), Plaza-Zabala
et al (2010), and
Shaham et al (1998)

Rat

C

Y

↓, ↔

Anker and Carroll
(2010b) and Regier et al
(2014)

Rat

C

FS

↓

Mantsch and Goeders
(1999)

Glucocorticoid antagonist: RU486 Rat

A

Y

↓

Simms et al (2012)

CRF1 receptor antagonists:
CP154,526, antalarmin, MTIP

Steroid hormones
Allopregnanolone

Corticosterone synthesis
inhibitor: ketoconazole
Noradrenaline

Rat

A, F

FS, Y

↓

Le et al (2011)

Alpha-2 agonists: clonidine,
lofexidine, guanfacine

Rat

A, C, H,
N

FS, Y

↓

Brown et al (2009),
Buffalari et al (2012),
Erb et al (2000), Le et al
(2011, 2005), Shaham
et al (2000b), Zislis et al
(2007)

NA synthesis inhibitor:
Nepicastat

Rat

C

FS, Y

↓

Schroeder et al (2013)

Rat

C, H

FD, FS, Y ↓, ↔

Brown et al (2012),
Shaham and Stewart
(1996), and Tobin et al
(2009, 2013)

D2-family antagonist: raclopride Rat

C, H

FD, FS, Y ↔

Brown et al (2012),
Shaham and Stewart

Alpha-1 antagonist: prazosin

Dopamine
D1-family antagonists:
SCH23390, SCH 39166
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Neurotransmitter/hormonal
systems and drugs

Species Training Stressor Effect
history

References
(1996), Tobin et al
(2009)

Mixed D1/D2 antagonists:
tetrahydropalmatine, flupenthixol

Rat

C, H

FS

↓

Figueroa-Guzman et al
(2010) and Shaham and
Stewart (1996)

D3-family antagonist: SB277011A

Rat

C

FS

↓

Xi et al (2004)

Reuptake blockers/releasers:
fluoxetine, dexfenfluramine

Rat

A

FS

↓

Le et al (2006, 1999)

5-HT 1A antagonist: WAY
100,635

Rat

A

Y

↓

Le et al (2009)

Rat

A, C

Y

↓

Fletcher et al (2008)

A

FS

↓

Le et al (2006)

A

FS, Y

↔

Cippitelli et al (2008)
Economidou et al (2007)

Serotonin

5-HT 2C agonist: Ro60-0175

5-HT3 antagonists: ondansetron, Rat
tropisetron
Cannabinoids
FAAH inhibitor: URB597

Rat
Rat

A

FS

↔

Rat

A, C, H,
N

FD, FS,
FSS, Y

↓, ↔

Beardsley et al (2005,
2010), Funk et al
(2014), Grella et al
(2014), Polter et al
(2014), Schank et al
(2012) and Sedki et al
(2015)

A

Y

↓

Nielsen et al (2012)

Rat

A, C

Y

↓

de Guglielmo et al
(2013) and Stopponi et
al (2012)

m-GLUR2/3 agonist: LY379268

Rat

A, C

FS

↓

Martin-Fardon and Weiss
(2012), Sidhpura et al
(2010), Zhao et al
(2006)

m-GLU5 antagonist: MTEP

Rat

C

FS

↓

Martin-Fardon and Weiss
(2012) and Sidhpura et
al (2010)

Rat,
mouse

A, C, F

FS, Y

↓, ↔

Boutrel et al (2005), Nair
et al (2008), PlazaZabala et al (2010),
Richards et al (2008 and
Zhou et al (2012)

Neuropeptide Y R2 and R5
antagonists: JNJ-31020028, Lu
AA33810

Rat

A, H

FD, FS

↓, ↔

Cippitelli et al (2011)
and Maric et al (2011)

Neurokinin 1 receptor
antagonist: L822429

Rat

A, C

FS, Y

↓

Schank et al (2014,
2011)

CB1 antagonist: SR-141716A
Dynorphin
Kappa antagonists: JDTic, NorBNI, RTI-194

Enkephalin/endorphin
δ receptor antagonist: SoRI9409 Rat
GABA
GABA agonist: pregabalin

Glutamate

Hypocretins
Hypocretin-1 receptor
antagonist: SB334867

Neuropeptides
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Neurotransmitter/hormonal
systems and drugs

Species Training Stressor Effect
References
history
↓
Neuropeptide S antagonist: RTI- Rat
C
Y
Schmoutz et al (2012)
118
↓
Nociceptin/orphanin receptor
Rat
A
FS, Y
Ciccocioppo et al (2014)
agonist: MT-7716
and de Guglielmo et al
(2014)
Others
PPARγ agonist: Pioglitazone

Rat

A

Y

↓

Stopponi et al (2013,
2011)

Alpha-3/beta-4 nACh partial
agonist: AT-1001

Rat

A

Y

↓

Cippitelli et al (2015)

Abbreviations for training history: A, alcohol; C, cocaine, F, food; H, heroin; M,
methamphetamine; N, nicotine. Abbreviations for stressors: FD, food deprivation (1
d); FS, intermittent footshock; FSS, forced swim stress; Y, yohimbine. Abbreviations
for symbols: ↓, decrease; ↔, no effect.

Table 3. Effect of Systemic Injections of Different
Pharmacological Agents on Stress-Induced Reinstatement of
Conditioned Place Preference
Neurotransmitter/hormonal
systems and drugs

Species Training Stressor Effect
history

References

CRF
Rat

C, M

FS

↓

Lu et al (2001)

Alpha-1 antagonist: Prazosin

Mouse

C

FSS, Y

↔

Mantsch et al (2010)

Alpha-2 agonist: Clonidine

Mouse

C

FSS, Y

↓, ↔

Beta-1 antagonist: betaxolol

Mouse

C

FSS

↓

Vranjkovic et al (2012)

Mouse

C

FSS, Y

↓

Mantsch et al (2010)
and Vranjkovic et al
(2012)

Rat

C

FSS

↓

Vaughn et al (2012)

Mouse

C, N

FSS

↓

Aldrich et al (2009,
2013), Eans et al
(2013), Grimwood et al
(2011), Jackson et al
(2013), McLaughlin et
al (2003) and Redila
and Chavkin (2008)

Cholecystokinin receptor A and Rat
B antagonists: Devazepide,
L365,260

C

FS

↓, ↔

Lu et al (2002)

NMDA 2B receptor antagonist:
ifenprodil

M

FSS

↔

Ma et al (2007)

CRF1 receptor antagonist:
CP154,526
Noradrenaline

Beta-2 antagonists:
Propranolol, ICI-118,551

Mantsch et al (2010)

Cannabinoids
Cannabinoid antagonist: AM251
Dynorphin
Kappa antagonists: Nor-BNI,
CJ-15,208, PF-04455242,
Zyklophin

Other transmitters

rat

Abbreviations for training history: A, alcohol; C, cocaine, M, morphine; N, nicotine.
Abbreviations for stressors: FS, intermittent footshock; FSS, forced swim stress; Y,
yohimbine. Abbreviations for symbols: ↓, decrease; ↔, no effect.
Neuropsychopharmacology, Vol 41, No. 1 (January 2016): pg. 335-356. DOI. This article is © © 2016 American College of
Neuropsychopharmacology and permission has been granted for this version to appear in e-Publications@Marquette.
American College of Neuropsychopharmacology does not grant permission for this article to be further
copied/distributed or hosted elsewhere without the express permission from American College of
Neuropsychopharmacology.

16

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Neuropsychopharmacology, Vol 41, No. 1 (January 2016): pg. 335-356. DOI. This article is © © 2016 American College of
Neuropsychopharmacology and permission has been granted for this version to appear in e-Publications@Marquette.
American College of Neuropsychopharmacology does not grant permission for this article to be further
copied/distributed or hosted elsewhere without the express permission from American College of
Neuropsychopharmacology.

17

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Bed Nucleus of Stria Terminalis and CeA
The bed nucleus of stria terminalis (BNST) and the CeA are
known to have important roles in stress responses (Davis et al, 2010;
LeDoux, 2000) that involve activation of noradrenaline and CRF
systems (Davis et al, 1997; Flavin and Winder, 2013; McGaugh, 2004;
Silberman and Winder, 2013). Studies using systemic or ventricular
drug injections have shown that CRF receptor antagonists and alpha-2
adrenoceptor agonists like clonidine (which inhibit noradrenaline cell
firing and release) decrease stress-induced reinstatement of drug
seeking and drug CPP (Mantsch et al, 2014; Shaham et al, 2000a;
Shalev et al, 2010) (Tables 2 and and3).3). Conversely, ventricular
injections of CRF or noradrenaline mimic the effect of intermittent
footshock stress on reinstatement (Brown et al, 2009; Erb et al, 2006;
Le et al, 2000; Shaham et al, 1997). Studies using endocrinology
methods (adrenalectomy, corticosterone replacement) have also
shown that CRF's role in footshock-induced reinstatement does not
involve stress-induced activation of the HPA axis, indicating a role of
extrahypothalamic CRF systems (Erb et al, 2001a; Lu et al, 2003).
Based on these results, investigators have studied the involvement of
CRF and noradrenaline in BNST and CeA in stress-induced
reinstatement and CPP. We describe these studies below. (Note: in
Box 3 we discuss in more detail the role of corticosterone and the HPA
axis in stress-induced reinstatement.)
Box 3. Corticosterone, the HPA Axis, and Stress-Induced
Reinstatement
As mentioned in the main text, studies using endocrinology
methods of adrenalectomy and adrenalectomy plus corticosterone
replacement showed that stress-induced activation of the HPA axis and
subsequent release of corticosterone does not have a role in stressinduced reinstatement of drug seeking (Erb et al, 1998; Le et al, 2000;
Shaham et al, 1997; Shalev et al, 2006, 2003; Graf et al, 2011).
However, at least in the case of cocaine, basal corticosterone levels
are critical for stress-induced reinstatement (Erb et al, 1998; Shalev et
al, 2003), suggesting a permissive role of the stress hormone in this
reinstatement. Additionally, exogenous administration of
corticosterone reinstates cocaine seeking (Deroche et al, 1997).
More recently, there is evidence for a role of corticosterone in
two emerging important phenomena related to stress-induced
reinstatement. The first is that as mentioned in section ‘Generality of
stress-induced reinstatement', footshock stress-induced reinstatement
is significantly stronger and more robust in rats with a history of
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extended (6 h/day) vs limited (1–2 h/day) access to cocaine (Mantsch
et al, 2014). Under these conditions, adrenalectomy before selfadministration training prevents stress-induced reinstatement while
the same manipulation after training is ineffective (Graf et al, 2011),
suggesting that cocaine-induced corticosterone-dependent
neuroadaptations are critical for footshock-induced reinstatement.
Second, there is evidence that footshock, under conditions in
which it has no effect on reinstatement on its own, strongly
potentiates the ability of both cocaine priming and cocaine cues to
reinstate drug seeking (Buffalari and See, 2009; Graf et al, 2013). The
mechanism/s underlying the ‘indirect' potentiation effect of stress is
largely unknown but it appears that corticosterone has a critical role.
Graf et al (2013) showed that this effect of mild stress is reversed by
adrenalectomy but not by systemic injections of the glucocorticoid
receptor antagonist RU486. Next, these authors showed that the
potentiating effect of mild stress on cocaine priming is mediated by a
novel mechanism of action in NAc that involves glucocorticoiddependent blockade of dopamine clearance by the monoamine
transporter, organic cation transporter 3 (OCT3).

The CRF projections from CeA to BNST, Erb and Stewart (1999)
showed that injections of the CRF receptor antagonist D-Phe CRF12–41
into the BNST (ventral region) but not CeA decrease footshock-induced
reinstatement of cocaine seeking. They also showed that CRF
injections into the BNST but not CeA reinstate cocaine seeking; this
finding was confirmed by Vranjkovic et al (2014). In agreement with
these findings, Wang et al (2006) showed that BNST but not CeA
injections of the selective CRF1 receptor antagonist CP-154,526
(Schulz et al, 1996) decrease footshock-induced reinstatement of
morphine CPP. However, while blockade or activation of CeA CRF
receptors had no effect on footshock-induced reinstatement, Erb et al
(2001a) reported data suggesting that a CRF projection from CeA to
BNST (Sakanaka et al, 1986) has a role in this reinstatement. They
used an asymmetric anatomical disconnection method (Gold, 1966)
and showed that injections of tetrototoxin (TTX, a sodium channel
blocker that inhibits neuronal activity) into the CeA in one hemisphere
and D-Phe CRF12–41 into the BNST in the contralateral hemisphere
decrease footshock-induced reinstatement of cocaine seeking.
Taken together, these results suggest that stress-induced
activation of CRF projections from CeA to BNST and subsequent
activation of CRF receptors (presumably the CRF1 subtype) in the
BNST are critical for stress-induced reinstatement of drug seeking and
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CPP. However, the circuitry (projection) data are based on the use of
TTX, which also inhibits fiber of passage and non-CRF neurons that
project to BNST (Cassell et al, 1999). Therefore, it is likely that within
the BNST, CRF-related mechanisms that are independent of the CeA to
BNST CRF projection also have a role in stress-induced reinstatement.

Noradrenaline in CeA and BNST and interaction between
noradrenaline and CRF in BNST. Leri et al (2002) showed that
injections of a mixture of beta-1 and beta-2 adrenoceptor antagonists
(betaxolol+ICI-118,551) into both the BNST (the injections were in
both dorsal and ventral BNST) and the CeA decrease footshockinduced reinstatement of cocaine seeking. Subsequently, Vranjkovic et
al (2014) showed that within the ventral BNST, this effect is mediated
by the beta-2 adrenoceptor: local ICI-118,551 but not betaxolol
injections decrease stress-induced reinstatement. Additionally, they
showed that ventral BNST injections of the beta-2 adrenoceptor
agonist clenbuterol, but not the beta-1 adrenoceptor agonist
dobutamine, mimic the effect of footshock on reinstatement. Additional
evidence for a role of BNST and CeA noradrenaline in stress-induced
reinstatement is that BNST and CeA injections of clonidine decrease
footshock-induced reinstatement of morphine CPP (Wang et al, 2001)
and footshock-induced reinstatement of nicotine seeking (Yamada and
Bruijnzeel, 2011). These data, however, are difficult to interpret in the
absence of additional anatomical and pharmacological controls,
because clonidine is highly lipophilic and it can readily diffuse to the
nearby areas, or in the case of the BNST, to the ventricles. Finally,
based on the earlier results of Leri et al (2002), an unexpected finding
of Yamada and Bruijnzeel (2011) is that CeA injections of the nonselective beta adrenoceptor antagonist propranolol have no effect on
footshock-induced reinstatement of nicotine seeking.
Ascending noradrenaline systems originate from two clusters of
neurons, the locus coeruleus (LC, A6) and the lateral tegmental nuclei
(A1, A2 (located in nucleus tractus solitarii, NTS), A4); these neurons
project to many brain areas via the dorsal and ventral noradrenergic
bundles, respectively (Kvetnansky et al, 2009; Moore and Bloom,
1979). The lateral tegmental nuclei, which provide the main source of
noradrenaline to BNST and CeA (Aston-Jones et al, 1999; Fritschy and
Grzanna, 1991), but not the LC, are critical for stress-induced
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reinstatement of drug seeking and CPP. 6-OHDA lesions of the ventral
noradrenergic bundle decrease footshock-induced reinstatement of
heroin seeking (Shaham et al, 2000b) and morphine CPP (Wang et al,
2001). In contrast, injections of clonidine or its charged analog ST-91
into the LC have no effect on this reinstatement (Shaham et al, 2000b;
Wang et al, 2001).
Finally, there is evidence that an interaction between CRF and
noradrenaline in the BNST is critical for footshock-induced
reinstatement of cocaine seeking. In an initial study, Brown et al
(2009) showed that reinstatement of cocaine seeking induced by
ventricular injections of noradrenaline is decreased by pretreatment
with the CRF receptor antagonist D-Phe CRF12–41. In contrast,
reinstatement induced by ventricular injections of CRF is not blocked
by the alpha-2 adrenoceptor agonist clonidine. These data suggest
that the role of CRF in stress-induced reinstatement is downstream
from stress-induced activation of noradrenaline systems. The likely
brain site for this noradrenaline-CRF interaction is the BNST.
Vranjkovic et al (2014) showed that reinstatement of cocaine seeking
induced by ventral BNST injections of the beta-2 adrenoceptor agonist
clenbuterol is blocked by local injections of the CRF1 receptor
antagonist antalarmin (Bornstein et al, 1998).
Taken together, stress-induced activation of lateral tegmental
noradrenergic nuclei and subsequent actions of noradrenaline in both
the BNST and CeA are critical for stress-induced reinstatement of drug
seeking and CPP. Additionally, within the ventral BNST, stress-induced
activation of CRF and subsequent stress-induced reinstatement are
downstream from stress-induced activation of lateral tegmental
noradrenergic nuclei that project to this brain area.

Other evidence for a role of BNST and CeA in stress-induced
reinstatement. Several other lines of evidence also indicate critical
roles for the BNST and CeA in stress-induced reinstatement of drug
seeking and CPP. Reversible inactivation of ventral BNST or CeA with
GABAa and GABAb receptor agonists (muscimol+baclofen) decreases
footshock-induced reinstatement of cocaine seeking (McFarland et al,
2004). Additionally, TTX injections into either the BNST or CeA
decrease footshock-induced reinstatement of heroin seeking (Shaham
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et al, 2000a) and this reinstatement is associated with increased CRF
mRNA in both brain areas (Shalev et al, 2001). However, both sets of
data should be interpreted with caution. As mentioned above, a
methodological issue with TTX inactivation data is that the drug
inactivates both cell bodies and fibers of passage. Additionally, the
relevance of the CRF mRNA expression data to CRF's role in stressinduced reinstatement is unclear, because within the BNST footshock
selectively increases expression in dorsal but not in ventral BNST,
while the pharmacological data described above are primarily based on
ventral BNST injections.
Other relevant evidence is that systemic injections of the beta-2
adrenoceptor antagonist ICI-118,551 decrease swim stress-induced
reinstatement of cocaine CPP and prevent increases in CRF mRNA in
BNST (but not CeA) in mice (McReynolds et al, 2014). However, under
somewhat different experimental conditions, exposure to swim stress
increases CRF mRNA in CeA in cocaine-experienced mice (Cleck et al,
2008). In agreement with the latter findings, Nawata et al (2012)
showed that a CRF receptor antagonist (alpha-helical-CRF9-41)
decreases footshock-induced reinstatement of methamphetamine
seeking in rats; additionally, using enzyme-linked immunosorbent
assay (ELISA) they showed that CRF protein levels in CeA are
increased after 10 but not 5 days of withdrawal from
methamphetamine. The relevance of the ELISA data to the
pharmacological data with the CRF receptor antagonist is unknown.
Finally, studies using markers of neuronal activity such as Fos
and pCREB (a downstream target of Fos activation) showed that swim
stress-induced reinstatement of cocaine CPP in mice is associated with
increased CREB activity (phosphorylation) in amygdala but not in BNST
(Kreibich and Blendy, 2004). In a subsequent study, however, Briand
et al (2010) showed that swim stress increases Fos expression in both
ventral and dorsal BNST and that reversible inactivation of the BNST
with lidocaine decreases swim stress-induced reinstatement of cocaine
CPP. Additionally, Buffalari and See (2011) showed that reversible
inactivation with muscimol+baclofen of the BNST decreases
yohimbine-induced reinstatement of cocaine seeking and yohimbineinduced potentiation of cue-induced cocaine seeking.
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Summary. The studies reviewed above indicate that the BNST
(primarily the ventral BNST) and CeA have important roles in stressinduced reinstatement of drug seeking across drug classes and are
also involved in stress-induced reinstatement of morphine and cocaine
CPP. These roles include stress-induced activation of the lateral
tegmental nuclei that provide the main noradrenergic innervation to
BNST and CeA, and potentially the CRF projection from CeA to BNST.
Within the BNST, stress-induced CRF activation and subsequent stressinduced reinstatement are likely downstream from stress-induced
activation of lateral tegmental noradrenaline neurons.

Ventral Tegmental Area, Media Prefrontal Cortex,
Orbital Frontal Cortex, and Nucleus Accumbens
Neuronal activity in the mesocorticolimbic dopamine system,
which comprises cell bodies in ventral tegmental area (VTA) that
project to medial prefrontal cortex (mPFC), orbital frontal cortex
(OFC), nucleus accumbens (NAc), amygdala, BNST, and other brain
areas, has an important role in reinstatement of drug seeking induced
by discrete cues (See, 2005), discriminative cues (Weiss, 2005),
contextual cues (Marchant et al, 2014), and drug priming (Kalivas and
McFarland, 2003; Pierce and Kumaresan, 2006; Self, 2004). Early
studies have shown that different stressors strongly and preferentially
activate the dopaminergic projection from VTA to mPFC (the
mesocortical dopamine system) (Bannon and Roth, 1983; Deutch and
Roth, 1990; Thierry et al, 1976). Subsequent studies, however,
showed that stressors can also activate the dopaminergic projection
from VTA to NAc (a component of the mesolimbic dopamine system)
(Cabib and Imperato, 1996; Kalivas and Stewart, 1991).
Based on these findings, the first two studies on intermittent
footshock-induced reinstatement of drug seeking explored the role of
mesolimbic dopamine. In the first study, Shaham and Stewart (1995)
showed that footshock-induced reinstatement of heroin seeking is
associated with increased dopamine release in NAc. In the second
study, they showed that systemic injections of the mixed dopamine
receptor antagonist flupenthixol decrease this reinstatement (Shaham
and Stewart, 1996). In a subsequent anatomical mapping study,
McFarland et al (2004) showed that reversible inactivation with
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muscimol+baclofen of VTA, dorsal mPFC, NAc core and shell, and
ventral pallidum (a downstream output of NAc via the ‘indirect'
pathway) decreases footshock-induced reinstatement of cocaine
seeking. Below, we describe subsequent mechanistic studies on the
role of different brain areas of the mesocorticolimbic system in stressinduced reinstatement of drug seeking and CPP.

Glutamate, CRF, and Kappa/dynorphin in VTA. Glutamate input to
VTA arrives from several brain regions (Geisler et al, 2007;
Omelchenko and Sesack, 2007) and controls the activity of VTA
dopamine neurons under basal conditions (Westerink et al, 1996;
White et al, 1995) and after stress exposure (Enrico et al, 1998;
Takahata and Moghaddam, 1998). Based on these studies, Wise and
colleagues studied the role of VTA glutamate in stress-induced
reinstatement of cocaine and heroin seeking. They showed that
footshock-induced reinstatement of both heroin and cocaine seeking is
associated with increased VTA glutamate release and that this
reinstatement is decreased by local blockade of ionotropic glutamate
receptors with kynurenic acid (Wang et al, 2005, 2012).
VTA dopamine and glutamate transmission is also controlled by
local CRF signaling (Kalivas et al, 1987; Ungless et al, 2003) from
unspecified sources and, as discussed above, CRF has a critical role in
stress-induced reinstatement of drug seeking and CPP. Based on these
findings, Wise and colleagues studied the role of VTA CRF in stressinduced reinstatement of cocaine seeking. In the first study, they
showed that VTA perfusion (via a microdialysis probe) of alpha-helical
CRF9–41 decreases footshock-induced reinstatement and that local CRF
perfusion reinstates cocaine seeking (Wang et al, 2005); see also
Wang et al (2009) for a replication of the VTA CRF effect on
reinstatement. Next, they showed that footshock-induced
reinstatement of cocaine seeking is decreased by VTA perfusion of a
selective CRF2 receptor antagonist or an inhibitor of the CRF binding
protein but not by a selective CRF1 receptor antagonist. Moreover,
they showed that VTA perfusion of CRF or CRF2 receptor agonists with
strong affinity for CRF-BP (binding protein) causes reinstatement of
cocaine seeking, whereas CRF receptor agonists that do not bind CRFBP are ineffective (Wang et al, 2007).
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These are surprising findings from two perspectives. The first is
that previous studies discussed above (see also Tables 2 and and3)3)
implicate CRF1 but not CRF2 receptors in stress-induced
reinstatement. The second is that anatomical studies indicate that
CRF1 receptors are the predominant postsynaptic CRF receptors in VTA
and that CRF2 receptor expression is not detected by traditional in situ
hybridization methods (Van Pett et al, 2000). Another issue to
consider in studies using putative selective CRF2 antagonists is that
their CRF2/CRF1 ratio selectivity is moderate, and some commonly
used CRF2 antagonists like antisauvagine-30 have behavioral effects in
CRF2 knockout mice, indicating actions on other receptors (Zorrilla et
al, 2013b).
More recent studies demonstrated a role of CRF1 receptors in
stress-induced reinstatement of cocaine seeking. Blacktop et al (2011)
showed that VTA injections of the CRF1 receptor antagonists
antalarmin or CP-376395 but not the CRF2 receptor antagonists
astressin-2B or antisauvagine-30 decrease footshock-induced
reinstatement of cocaine seeking in rats. Additionally, VTA injections of
the CRF1 receptor agonist cortagine but not the CRF2 receptor agonist
rat urocortin II mimic the effect of footshock stress on reinstatement.
Chen et al (2014a) showed that local viral-mediated knockdown of VTA
CRF1 receptors decreases food deprivation stress-induced
reinstatement of cocaine seeking in mice. Vranjkovic et al (2014) also
showed that injections of the beta-2 adrenoceptor antagonist ICI188,551 into the BNST in one hemisphere and the CRF1 receptor
antagonist antalarmin into the VTA of the contralateral hemisphere
decrease footshock-induced reinstatement of cocaine seeking. These
data suggest a potential role of the CRF projection from BNST to VTA
(Rodaros et al, 2007), which is activated by noradrenergic projections
to BNST (Aston-Jones et al, 1999), in stress-induced reinstatement of
cocaine seeking. In this regard, the BNST projection to VTA is also
activated during swim stress-induced reinstatement of cocaine CPP in
mice, as assessed by double labeling of the activity marker Fos with
the retrograde tracer fluorogold gold (injected in VTA) in ventral BNST
(Briand et al, 2010).
Two recent studies by Kauer, Pierce and colleagues demonstrate
a role of kappa/dynorphin signaling in VTA in cold swim stress-induced
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reinstatement of cocaine seeking in rats (Graziane et al, 2013; Polter
et al, 2014). In this stress reinstatement procedure, short (4–5 min)
exposure to cold swim reinstates cocaine seeking 24 h later (Conrad et
al, 2010). These studies were inspired by earlier studies on the
regulation of VTA dopamine transmission by local kappa/dynorphin
signaling (Ford et al, 2007; Margolis et al, 2003) and the findings that
systemic injections of KOR antagonists decrease stress-induced drug
seeking in rats and stress-induced reinstatement of drug CPP in mice
(Tables 2 and and3)3) (Beardsley et al, 2005; Redila and Chavkin,
2008). In the first study, Graziane et al (2013) showed that systemic
injections of the KOR antagonist Nor-BNI rescue swim stress-induced
abolishment of long-term potentiation (LTP) at GABAergic synapses on
VTA dopaminergic neurons. Next, they showed that VTA injections of
Nor-BNI decrease stress-induced reinstatement of cocaine seeking. In
the second study, Polter et al (2014) showed that acute exposure to
swim stress blocks normal LTP at GABAergic synapses on VTA
dopaminergic neurons for up to 5 days, an effect dependent on KOR,
and that surprisingly, systemic injections of Nor-BNI several hours
after swim stress exposure also decrease the stressor's effect on
reinstatement 24 h later.

Summary. The studies reviewed above indicate that footshock stressinduced activation of CRF and glutamate transmission in VTA is critical
for the stressor's effect on reinstatement of drug seeking. A recent
study by Vranjkovic et al (2014) further suggests that glutamatergic
(Georges and Aston-Jones, 2002) and/or CRF (Rodaros et al, 2007)
projections from BNST to VTA are the source of this activation. There
is also evidence that KOR-mediated stress-induced alterations in
GABAergic transmission in VTA have a critical role in the effect of cold
swim stress on reinstatement of cocaine seeking.

Dopamine and glutamate in NAc, mPFC, and OFC. Studies using
intracranial injections of different dopamine receptor antagonists have
demonstrated an important role of dopamine transmission in dorsal
mPFC (prelimbic area) and OFC in stress-induced reinstatement of
cocaine seeking. Capriles et al (2003) showed that dorsal (but not
ventral or infralimbic area) mPFC and OFC injections of the D1-family
receptor antagonist SCH23390 but not the D2-family receptor
antagonist raclopride decrease footshock-induced reinstatement of
cocaine seeking. McFarland et al (2004) showed that dorsal mPFC
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injections of the mixed dopamine receptor antagonist flupenthixol
decrease this reinstatement. Sanchez et al (2003) showed that
SCH23390 injections into dorsal mPFC decrease restraint stressinduced reinstatement of cocaine CPP. Dorsal mPFC dopamine and
neuronal activity in this brain area also have a role in yohimbineinduced reinstatement of palatable food seeking in male and female
rats (Calu et al, 2013; Cifani et al, 2012; Nair et al, 2011) and acute
food deprivation-induced reinstatement of heroin seeking (Tobin et al,
2013). As VTA dopamine neurons project to mPFC and OFC (Moore
and Bloom, 1979), the results from the studies reviewed above
indicate that stress-induced activation of the dopaminergic projections
from VTA to mPFC (Thierry et al, 1976) and OFC is critical for stressinduced reinstatement. This activation involves D1-family receptors
which, in the mPFC, are expressed on pyramidal cells where they
promote excitability primarily by increasing NMDA receptor-mediated
effects (Lewis and O'Donnell, 2000; Seamans et al, 2001).
McFarland et al (2004) provided additional evidence that the
circuit controlling footshock-induced reinstatement of cocaine seeking
includes the dopaminergic projection from VTA to dorsal mPFC
(prelimbic area), and also provided evidence that the glutamatergic
projection from dorsal mPFC to NAc core (Sesack et al, 1989) and
potentially the GABAergic projection from NAc shell to VTA (Zahm et
al, 2001) (the ‘direct' striatal pathway) have a role in this
reinstatement. They showed that (1) reversible inactivation of dorsal
mPFC decreases both footshock-induced reinstatement and glutamate
release in NAc core, (2) reversible inactivation of NAc shell and core,
and as mentioned above the VTA, decreases this reinstatement, and
(3) that reversible inactivation of NAc shell also decreases stressinduced dopamine release in dorsal mPFC. These authors also showed
that reversible inactivation of the ventral pallidum, a main output
region of the striatal indirect pathway (Gerfen, 1992), decreases
footshock-induced reinstatement. This circuit scheme, however, is
speculative in the absence of more direct evidence from studies using
classical anatomical asymmetrical disconnection procedures (Setlow et
al, 2002) or more recent projection-specific inhibition using
optogenetic (Stefanik et al, 2013) or chemogenetic (Mahler et al,
2014) methods.
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Evidence for a role of NAc dopamine in stress-induced
reinstatement is somewhat mixed. Shaham and Stewart (1995)
showed that footshock-induced reinstatement of heroin seeking is
associated with increased dopamine levels in NAc. In contrast,
McFarland et al (2004) showed that footshock-induced reinstatement
of cocaine seeking is not associated with increased dopamine release
in NAc and that flupenthixol injections into NAc core have no effect on
this reinstatement. However, Xi et al (2004) showed that injections of
the preferential D3 receptor antagonist SB-277011A into NAc
(injections targeted primarily NAc shell) decrease footshock-induced
reinstatement of cocaine seeking. Additionally, Tobin et al (2013)
showed that SCH23390 injections into NAc shell but not core decrease
food deprivation-induced reinstatement of heroin seeking. Thus, one
possible account of these potentially discrepant results is that NAc
shell but not core dopamine is critical for stress-induced reinstatement
of drug seeking.
Finally, a very recent study by Wheeler and colleagues suggests
that at least for one stressor, a bitter quinine solution, reinstatement
of cocaine seeking is associated with decreased tonic NAc dopamine
levels, as assessed by in vivo voltammetry (Twining et al, 2015). They
showed that in cocaine-experienced rats, exposure to quinine
reinstates cocaine seeking, and that in drug-naïve rats, the same
manipulation decreases tonic dopamine levels in NAc. Both of these
effects were reversed by blockade of VTA CRF1 receptors. Together,
with the previous results reviewed above, the results from this study
suggest that both increases and decreases in NAc dopamine can have
a role in stress-induced drug seeking.

Summary. D1 receptor-mediated dopamine transmission in dorsal
mPFC and the glutamatergic projection from this brain area to NAc
core are critical for stress-induced reinstatement of cocaine seeking.
This reinstatement also likely involves activation of the NAc GABAergic
projections to VTA (the direct pathway) and ventral pallidum (the
indirect pathway), as well as increased dopamine transmission in NAc
shell. A recent study using intraoral delivery of quinine solution as the
stressor suggests that stress-induced reinstatement can also be
triggered by decreases in NAc dopamine tone.

Median and Dorsal Raphe Nuclei
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Many studies over the last several decades have implicated
central serotonin in stress responses (Chaouloff, 1993; Maier, 1984;
Maier and Watkins, 2005; Stone, 1983). This literature has led to
studies on the role of serotonin in the two main cell body regions of
brain serotonergic neurons—median raphe nucleus (MRN) and dorsal
raphe nucleus (DRN) (Hale and Lowry, 2011; Vertes, 1991; Vertes et
al, 1999)—in stress-induced reinstatement of alcohol seeking in rats
and stress-induced reinstatement of cocaine and morphine CPP.

Role of MRN in stress-induced reinstatement of alcohol seeking.
Le et al (1999) showed that systemic injections of the serotonin
reuptake blocker fluoxetine, which increases brain serotonin levels,
decrease footshock-induced reinstatement of alcohol seeking,
indicating that serotonin negatively regulates this reinstatement. This
negative regulation involves the MRN. Local injections of the selective
5-HT1a autoreceptor agonist 8-OH-DPAT, which decrease serotonin
cell firing and release (Mongeau et al, 1997), mimic the effect of
intermittent footshock on reinstatement (Le et al, 2002). Additionally,
these authors showed that MRN injections of the non-selective CRF
receptor antagonist D-Phe CRF12–41 decrease footshock-induced
reinstatement of alcohol seeking while MRN injections of very low
doses of CRF (10 ng) partially mimic the stressor's effect on
reinstatement. A physiological mechanism that connects the similar
effects of 8-OH-DPAT and low-dose CRF injections in MRN on
reinstatement is that low CRF doses, like 8-OH-DPAT, decrease
serotonin cell firing and release (Kirby et al, 2000; Price et al, 1998).
However, to date, this effect has only been reported for DRN but not
for MRN neurons. Finally, Le et al (2008) showed that reversible
inactivation of the MRN with the GABAa agonist muscimol reinstates
alcohol seeking. However, the relevance of this observation to
serotonin's role in stress-induced reinstatement is questionable
because this effect is not reversed by lesions of serotonin-containing
neurons in the brain.

Role of DRN in stress-induced reinstatement of morphine and
cocaine CPP. Results from CPP reinstatement studies from the Kirby
and Chavkin laboratories implicate the DRN serotonergic cell body
region in stress-induced reinstatement. Staub et al (2012) showed
that swim stress-induced reinstatement of morphine CPP is associated
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with increased GABAergic postsynaptic neuronal activity that leads to
inhibition of DRN serotonin neurons, and that this inhibitory effect
involves local CRF signaling. In a follow-up study, Li et al (2013)
showed that increasing GABAergic inhibitory transmission by DRN
muscimol injections reinstates morphine CPP while inhibition of
GABAergic neurons by bicuculline (a GABAa receptor antagonist)
decreases swim stress-induced reinstatement.
There is also evidence for a role of kappa/dynorphin signaling in
DRN in stress-induced reinstatement of cocaine CPP in mice. Land et al
(2009) showed that DRN injections of the KOR antagonist Nor-BNI
decrease social stress-induced reinstatement of cocaine CPP in mice.
Their results from experiments examining the role of kappa/dynorphin
in DRN in aversive behavior also suggest that the serotonergic
projection from DRN to NAc likely has a role in the local inhibitory
effect of Nor-BNI in DRN on stress-induced reinstatement of cocaine
CPP; however, this possibility was not empirically tested. In a
subsequent study, the Chavkin laboratory showed that KOR-mediated
social stress-induced activation of p38 mitogen-activated protein
kinase (MAPK) in DRN serotonergic neurons has a critical role in
stress-induced reinstatement of cocaine CPP (Bruchas et al, 2011). In
this study, the authors first showed that exposure to social defeat
stress, which induces reinstatement of cocaine seeking, activates
p38MAPK in DRN, and that this effect is reversed by Nor-BNI and is
not observed in KOR knockout mice. They then showed that viralmediated selective deletion of p38MAPK in DRN serotonin neurons
decreases social stress-induced reinstatement of cocaine CPP.

Summary. The results of the studies reviewed above indicate an
important role for an interaction between CRF and serotonin in MRN in
footshock stress-induced reinstatement of alcohol seeking. There is
also evidence for a role of DRN serotonergic neurons, which involves
both CRF and kappa/dynorphin. A question for future research is which
serotonergic projection areas contribute to the distinct roles of MRN
and DRN in stress-induced reinstatement in the operant model and the
CPP model (Figure 3).

Neuropsychopharmacology, Vol 41, No. 1 (January 2016): pg. 335-356. DOI. This article is © © 2016 American College of
Neuropsychopharmacology and permission has been granted for this version to appear in e-Publications@Marquette.
American College of Neuropsychopharmacology does not grant permission for this article to be further
copied/distributed or hosted elsewhere without the express permission from American College of
Neuropsychopharmacology.

30

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Figure 3. The circuitry of stress-induced reinstatement of drug seeking. The figure
depicts brain regions, neuronal projections, and neurotransmitters implicated in
stress-induced reinstatement of drug seeking and stress-induced reinstatement of
drug CPP (see text for details). Filled lines represent established projections and
dashed lines represent putative projections. Abbreviations: CeA, central nucleus of the
amygdala; DRN, dorsal raphe nucleus, MRN, median raphe nucleus; mPFC, medial
prefrontal cortex; NAc: nucleus accumbens; OFC, orbitofrontal cortex; vBNST, ventral
BNST; VP, ventral pallidum; VTA, ventral tegmental area.

Translational Human Research
In this section, we describe results from several human
laboratory studies and two double-blind clinical trials in which
pharmacological agents that decrease stress-induced reinstatement of
drug seeking were tested for their effects on drug craving and relapse
in humans. These include the alpha-2 adrenoceptor agonists,
clonidine, guanfacine, and lofexidine, the alpha-1 adrenoceptor
antagonist, prazosin, and the CRF1 receptor antagonist, pexacerfont.
Figures 4 and and55 show comparative data on the effect of alpha-2
adrenoceptor agonists and CRF1 receptor antagonists on stressinduced reinstatement of drug seeking in rats and stress-induced
craving and time to first lapse in humans.
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Figure 4. Effects of alpha-2 adrenoceptor agonists on stress-induced reinstatement in
rats and stress-induced craving in humans. (a) Rat studies: Data are mean±SEM nonreinforced active lever presses after exposure to intermittent footshock or no shock
immediately prior to the reinstatement tests in rats with a history of heroin, cocaine,
speedball (a heroin-cocaine combination), or alcohol self-administration. The session
duration was 3 h for heroin, cocaine, and speedball, and 1 h for alcohol. The
intermittent footshock duration was 15 min for heroin, cocaine, and speedball, and
10 min for alcohol. Clonidine and lofexidine were injected 25–45 min before
intermittent footshock exposure. (b) Human studies: Left side: Data are mean±SEM
subjective craving responses assessed on an ordinal Likert scale in opiate users
(maintained on naltrexone) or cocaine users who were pretreated with lofexidine or
clonidine, respectively, or placebo and exposed to a guided imagery stress or no stress
(neutral guided imagery) manipulation. Right side: days to first lapse in human
subjects that received chronic placebo or clonidine in a clinical trial. Data were
redrawn from Erb et al (2000), Highfield et al (2001), Jobes et al (2011), Kowalczyk et
al (2014), Le et al (2005), Shaham et al (2000b), and Sinha et al (2007). *Different
from the vehicle (0 dose) in the stress condition or different from the placebo
condition, p<0.05.
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Figure 5. Effects of CRF1 receptor antagonists on stress-induced reinstatement in rats
and stress-induced craving in humans. (a) Rat studies: Data are mean±SEM nonreinforced active lever presses after exposure to intermittent footshock or no shock
immediately prior to the reinstatement tests in rats with a history of heroin, cocaine,
or alcohol self-administration. The session duration was 3 h for heroin and cocaine,
and 1 h for alcohol. The intermittent footshock duration was 15 min for heroin and
10 min for cocaine and alcohol. The CRF1 receptor antagonist CP-154,526 was injected
30 min before intermittent footshock exposure. (b) Human study: Data are mean±SEM
subjective craving responses assessed on an ordinal Likert scale in alcohol users who
were pretreated with the CRF1 receptor antagonist pexacerfont and exposed to a
guided imagery stress or no stress (neutral guided imagery) manipulation. Data were
redrawn from Kwako et al (2015), Le et al (2000) and Shaham et al (1998). *Different
from the vehicle (0 dose) in the stress condition, p<0.05.

Human Laboratory Studies
In 1999, Sinha and colleagues introduced a laboratory model to
determine, in a cause-effect manner, the effect of stress on drug
craving under controlled laboratory conditions (Sinha, 2001; Sinha et
al, 1999). They and other investigators showed that certain stressors,
including guided imagery stress, the Trier Social Stress Task, and
systemic CRF injections induce physiological (eg, increased cortisol
release) and psychological (eg, increased anxiety) stress responses
and increase self-reports of drug craving (Back et al, 2010; Sinha,
2009; Sinha et al, 1999). From the perspective of drug relapse, an
important finding from these studies is that physiological and
psychological (including drug craving) stress responses in the
laboratory predict, to some degree, subsequent drug relapse (Back et
al, 2010; Higley et al, 2011; Sinha et al, 2006, 2011a).

Alpha-2 adrenoceptor agonists. In several studies, investigators
determined the effects of alpha-2 adrenoceptor agonists on stress- and
cue-induced craving in opiate, cocaine, heroin, and nicotine (smokers)
users. In an initial preliminary study, Sinha et al (2007) showed that in
opiate users maintained on naltrexone, lofexidine treatment
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(2.4 mg/day) decreases both stress- and cue-induced opiate craving.
Similar findings were observed in a larger sample study with cocaine
users in which Jobes et al (2011) showed that clonidine (0.1 or
0.2 mg) administration decreases stress- and cue-induced cocaine
craving (Figure 3).
In another study, Fox et al (2012) determined the effects of
guanfacine (up to 3 mg/day) on stress-, cue-, and stress+cue-induced
drug craving in cocaine-dependent individuals who also use alcohol
and nicotine (smokers). They showed that guanfacine decreases
stress- and cue-induced nicotine craving. Guanfacine also modestly
decreased cue-induced cocaine craving, anxiety, and arousal, but not
stress-induced craving. However, the latter negative finding may
reflect a floor effect, because the stress manipulation caused a very
weak craving response in the placebo group.
More recently, McKee et al (2014) showed that in human
smokers guanfacine treatment (3 mg/day) decreases both stressinduced drug craving and stress-induced smoking in the laboratory. In
another study, Fox et al (2014) examined the effect of guanfacine (2
or 3 mg/day) on stress-, cue, and stress+cue-induced craving in male
and female cocaine users who also use alcohol and nicotine (smokers).
A surprising finding in this study was that guanfacine selectively
decreased cocaine craving, alcohol craving, anxiety, and negative
emotion following exposure to all three experimental conditions in
females but not in males. In contrast, guanfacine decreased stress and
cue-induced nicotine craving in both males and females. Finally, in a
very recent study Moran-Santa Maria et al (2015a) showed that in
cocaine users acute administration of guanfacine (2 mg) has no effect
on cocaine craving in response to stress, cue, or stress+cue. In
interpreting these data, two pharmacological factors should be
considered. The first is that, unlike the previous guanfacine studies of
Sinha and colleagues in which guanfacine was given chronically for
several weeks, in the Moran-Santa Maria et al (2015a) study, the drug
was given acutely. The second is that the data of Sinha and colleagues
suggest that the minimal effective dose of guanfacine in the laboratory
studies is ~3 mg, which is higher than the dose used in Moran-Santa
Maria et al study.
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Findings from three other human laboratory studies in which
yohimbine was used to induce drug craving and seeking provide
additional support to the translational value of stress-induced
reinstatement studies in laboratory animals. In these studies, doses of
yohimbine that induced physiological and psychological stress
responses increased alcohol craving (Umhau et al, 2011), potentiated
cue-induced cocaine craving (an effect that was more pronounced in
females), and increased opiate seeking in a choice-based
(hydromorphone vs money) progressive ratio task (Greenwald et al,
2013). Thus, despite the interpretation issues related to yohimbine's
effects in rat reinstatement studies (Box 2), in humans, the drug
induces an aversive stress-like state of which one manifestation is
increased drug craving and seeking.
Finally, as discussed elsewhere (Bossert et al, 2013), an
unexpected finding in the human studies was that alpha-2
adrenoceptor agonists decreased both stress- and cue-induced drug
craving. This was unexpected because in rat studies the alpha-2
adrenoceptor agonists selectively decreased footshock stress-induced
reinstatement but not drug priming- or cue-induced reinstatement
(Erb et al, 2000; Highfield et al, 2001), but see Smith and Aston-Jones
(2011) for different results. A possible account for these different
findings is that in rats cue exposure primarily induces an appetitive
motivational state (See, 2005) while in humans, cue exposure also
induces stress-like physiological and psychological states that are
similar to those induced by stress exposure (Sinha et al, 1999, 2000).

Alpha-1 adrenoceptor and CRF1 receptor antagonists. Two studies
determined the effects of the alpha-1 adrenoceptor antagonist
prazosin or the CRF1 receptor antagonist pexacerfont on stress- and
cue-induced alcohol craving. Fox et al (2012) showed that in alcohol
users prazosin (16 mg/day) decreases stress-induced craving and
negative emotions. Prazosin also decreased cue-induced negative
emotion self-reports, but had no effect on cue-induced craving. The
negative data might be due to a floor effect, because of a weak cueinduced craving in the placebo group.
Most recently, Kwako et al (2015) determined the effects of oral
pexacerfont (300 mg/day for 7 days and 100 mg/day for 23 days) on
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stress- and cue-induced alcohol craving in ‘anxious' alcohol-dependent
subjects. This study was inspired by the large and remarkably
consistent preclinical literature on the effect of CRF receptor
antagonists on escalation of drug intake, stress-like physiological and
psychological withdrawal symptoms, and stress-induced reinstatement
of drug seeking across drug classes (Heilig and Koob, 2007; Koob,
2008; Shalev et al, 2010; Zorrilla et al, 2013a). In sharp contrast to
the preclinical data, pexacerfont treatment had no effect on stress- or
cue-induced alcohol craving, emotional responses, or anxiety (Figure
4). Pexacerfont also had no effect on neural responses (fMRI) to
alcohol-related or affective-related cues.

Clinical Trials
The data from the laboratory studies described above provide
evidence for the human ‘translational' value of the stress-induced
reinstatement model. However, from a perspective of human drug
relapse, a critical test for the predictive validity of the model is
whether medications identified in the rat model show efficacy in the
drug user's environment (Epstein et al, 2006). Kowalczyk et al (2014)
recently determined in heroin users whether the clinical efficacy of
buprenorphine would be enhanced by clonidine. In this relapse
prevention study, the subjects first received contingency management
to facilitate initial abstinence. Subjects who successfully maintained
abstinence were randomized to receive clonidine (0.1 mg for 1 week,
0.2 mg for the next week, and 0.3 mg for the rest of the study, n=61)
or placebo (n=57) for 14 weeks. The main dependent measures were
time to lapse (defined as any opiate positive or missed urines) and
time to relapse (defined as any consecutive lapses), as well as
baseline craving, and stress- and cue-induced craving in the subjects'
home environment, as assessed by real-time ecological momentary
assessment (EMA) (Epstein et al, 2009). The main findings of the
study were that clonidine treatment increased the time to lapse (from
25 to 35 days) (Figure 4) and decreased baseline craving and stressinduced craving. In contrast, clonidine had no effect on relapse rates
once a lapse had occurred.
In the context of our review, a study of Krupitsky et al (2013),
which likely was not based on the stress-induced reinstatement studies
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in the animal model, is also relevant. In this 6-month clinical trial,
these authors determined whether guanfacine (1 mg/day) would
decrease relapse rates in opiate users maintained on naltrexone. The
main finding was that guanfacine had no effect on relapse rates but
decreased self-reports of stress and craving. While the study included
a large number of subjects (n=75 per group) and was well designed, a
potential methodological issue was the use of a low guanfacine dose
(1 mg). The studies described in section ‘Human laboratory studies'
suggest that the effective dose of guanfacine in the laboratory studies
is ~3 mg (Fox et al, 2014; McKee et al, 2014).

Summary
The results of the human studies with alpha-2 adrenoceptor
agonists and prazosin appear to support the translational utility of the
stress-induced reinstatement model. However, unlike the uniform
effects of these agonists on stress-induced reinstatement in the rat
model, the effects in the human studies are more variable, and some
of the human studies reported negative results (Krupitsky et al, 2013;
Moran-Santa Maria et al, 2015a), possibly due to the use of doses that
were lower than those used in the studies that report positive effects.
The human studies also suggest potential sex differences in the
efficacy of alpha-2 adrenoceptor agonists (Fox et al, 2014), a factor
that has not been considered in the preclinical studies. What might
account for the more heterogeneous/variable results in the clinical
preclinical studies?
We propose that four factors might be particularly important.
The first is the fact that rat or mouse studies are invariably performed
using highly homogenous subjects of the same or similar age, sex,
drug exposure duration, and in many cases likely from a limited
number of litters (and therefore a homogenous genetic background).
In contrast, the human studies are performed with a highly
heterogeneous subject population of different ages, duration of drug
use, race, and also includes both sexes. The second factor is the more
flexible nature of studies using animal models, which allows
investigators to adjust both experimental parameters, including drug
doses, to determine the effects of pharmacological agents on
reinstatement under more than one experimental set-up. In contrast,
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human studies are typically performed double-blind from start to end,
which increases statistical power but may result in negative data due
to two main sources that have a significant role in the studies
reviewed above: drug doses that were likely too low and experimental
manipulations (stress- or cue-induced reinstatement) that in some
studies had minimal effect on craving, making it difficult to detect a
reliable effect of the medication. Third, a significant issue in assessing
the efficacy of medications to treat drug addiction is compliance
(Weiss, 2004), an issue that likely also played a role in the studies
reviewed above. Fourth, the different types of stressors used in the
preclinical studies (exposure to a physical aversive stimulus such as
footshock, restraint, or cold water) vs the stressors used in the clinical
studies (exposure to psychological stressors like stress imagery or the
Trier Social Stress Task) is an issue to consider in ‘translational'
studies on stress-induced reinstatement of drug seeking in which
different results are observed in human studies vs. animal models.
Finally, the negative results with pexacerfont (Kwako et al,
2015) indicate that it is unrealistic to expect that all potential
medications identified in animal models of psychiatric disorders,
including the stress-induced reinstatement model, will readily translate
to the human condition. However, these negative data are particularly
disappointing because, as mentioned above, they are based on
unparalleled convergence from multiple animal models of drug
addiction and results that were independently demonstrated in
multiple laboratories using different drugs of abuse under different
experimental conditions (Heilig and Koob, 2007; Koob, 2008; Sarnyai
et al, 2001; Shalev et al, 2010).

Conclusions and Future Directions
The demonstration that a brief exposure to uncontrollable and
unpredictable intermittent footshock stress reinstates heroin seeking in
rats (Shaham and Stewart, 1995) has stimulated research by many
preclinical investigators on behavioral and neuropharmacological
mechanisms of stress-induced reinstatement of drug seeking and CPP.
The preclinical model of stress-induced reinstatement and the
demonstration that stress can provoke drug craving under controlled
experimental conditions (Sinha et al, 1999) have also stimulated
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translational research to identify potential medications that specifically
target stress-induced craving and relapse in humans. In this review,
we summarized this field of research to consolidate the current state
of knowledge within a single review. The results from the studies
reviewed suggest at least four future lines of investigation.
The first is the investigation of the synaptic and cellular
mechanisms of stress-induced reinstatement. Several studies have
explored this question for swim stress-induced reinstatement of
cocaine seeking in rats (Chirila et al, 2014; Kreibich and Blendy, 2004;
Polter et al, 2014) and social defeat-induced reinstatement of cocaine
CPP in mice (Bruchas et al, 2010, 2011; Land et al, 2009). At present,
however, the synaptic and cellular mechanisms of stress-induced
reinstatement are largely unknown.
The second is the investigation of circuitry mechanisms of
stress-induced reinstatement, using neuroscience methods that go
beyond classical neuropharmacological and neuroanatomical methods.
In the ‘relapse/reinstatement' field, investigators recently have begun
to incorporate modern chemogenetic (Bossert et al, 2011; Cruz et al,
2014; Fanous et al, 2012; Mahler et al, 2014) and optogenetic (Lee et
al, 2013; Ma et al, 2014; Stefanik et al, 2013) methods to study brain
circuits of context-, cue-, and drug priming-induced reinstatement of
drug seeking, but these methods have not yet been used for stressinduced reinstatement.
The third is the study of sex differences in stress-induced
reinstatement of drug seeking. In this regard, footshock stressinduced reinstatement of drug seeking is observed in both male and
female rats (Shaham and Stewart, 1995). Additionally, recent studies
on sex differences and the role of ovarian hormones in stress-induced
reinstatement have used yohimbine as a stressor and the results are
mixed. Two studies showed that yohimbine effect on reinstatement of
cocaine and methamphetamine seeking is somewhat stronger in
female rats than in male rats (Anker and Carroll, 2010a; Cox et al,
2013). However, other studies have shown neither sex differences nor
a role of ovarian hormones in yohimbine-induced reinstatement of
nicotine or palatable food seeking (Cifani et al, 2012; Feltenstein et al,
2012; Pickens et al, 2012). A question for future research is whether
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sex differences would be observed in the mechanisms that mediate
stress-induced reinstatement.
Finally, during human abstinence, stress exposure often occurs
in the presence of contexts and cues previously associated with drug
use and the drug itself in the case of an initial lapse (Epstein et al,
2009). Human laboratory studies also indicate that stress can
potentiate cue-induced drug craving (Fox et al, 2014; George et al,
2008; Moran-Santa Maria et al, 2015b). Additionally, studies using the
reinstatement model demonstrate that stress exposure potentiates the
response to both cues (Buffalari and See, 2009; Liu and Weiss, 2002b)
and drug priming injections (Graf et al, 2013). Thus, from a
translational perspective, mechanistic studies on stress-induced
potentiation of the response to drug cues or contexts after extinction
or without prior extinction may lead to the identification of new targets
for developing medications for relapse prevention.
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